Adicet Bio market cap ACET
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $37.4M
- Highest close in our data
- $911.4M
- Nov 2022
Adicet Bio is worth $37.4M at the close on Oct 23, 2026, at $3.99 a share.
That is down 50% over the last year and down 86% over five years.
Its highest close in our data was $911.4M in Nov 2022.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $37.4M | $37.4M | $89.8M | −53% |
| 2025 | $79.7M | $43.5M | $101.5M | +4% |
| 2024 | $76.3M | $74.2M | $193.1M | −7% |
| 2023 | $81.6M | $51.4M | $383.9M | −79% |
| 2022 | $383.1M | $339.8M | $911.4M | −31% |
| 2021 | $558.9M | $220.3M | $558.9M | +103% |
| 2020 | $275.4M | $35.4M | $283.8M | +472% |
| 2019 | $48.1M | $39.7M | $371.6M | −81% |
| 2018 | $246.9M | $225.3M | $424.7M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Adicet Bio's size, closest first, today.
| Company | Market cap |
|---|---|
| ACETAdicet Bio | $37.4M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $69M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Adicet Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.